Secukinumab in the treatment of parenchymal neuro-Behçet’s syndrome-Reference-Cited by-同舟云学术

Secukinumab in the treatment of parenchymal neuro-Behçet’s syndrome

Published:2022-04-13 Issue:9 Volume:61 Page:e277-e279
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Liu Jinjing¹^ORCID,Tian Jimei²,Wang Zhimian¹,Wang Li¹^ORCID,Huang Can¹,Zhou Jiaxin¹^ORCID,Zeng Xiaofeng¹^ORCID,Zhao Yan¹,Zheng Wenjie¹^ORCID

Affiliation:

1. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Rheumatology, Ministry of Education, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases , Beijing

2. Department of Rheumatology, Heping Hospital Affiliated to Changzhi Medical College, Chang Zhi, Shan Xi, China

Funder

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac222/43470055/keac222.pdf

Reference8 articles.

1. Management of Behcet’s syndrome;Karadag;Rheumatology,2020

2. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease;Belghith;Cytokine,2018

3. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease;Geri;J Allergy Clin Immunol,2011

4. RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Behçet’s Disease;Hamzaoui;J Neuroimmunol,2011

5. CSF levels of cytokines in neuro-Behçet’s disease;Borhani Haghighi;Clin Neurol Neurosurg,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Behçet's syndrome;The Lancet;2024-03

2. Anti-IL17 treatment in childhood chronic rheumatic diseases;Expert Opinion on Biological Therapy;2023-05-04